Profil
Mr. John Ruesch is a Chief Technical Operations Officer at BioCryst Pharmaceuticals, Inc. Mr. Ruesch was previously employed as a SVP-Pharmaceutical Sciences & Technical Operations by Astria Therapeutics, Inc., a Vice President-Pharmaceutical Development by Surface Oncology, Inc., and a Senior Director-Drug Product Development by Biogen, Inc. He received his undergraduate degree from Valparaiso University and an MBA from Kellogg School of Management.
Postes actifs de John Ruesch
| Sociétés | Poste | Début |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 23/01/2026 |
Anciens postes connus de John Ruesch
| Sociétés | Poste | Fin |
|---|---|---|
| ASTRIA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2025 |
| SURFACE ONCOLOGY, INC. | Corporate Officer/Principal | 01/01/2023 |
| BIOGEN INC. | Corporate Officer/Principal | 01/12/2021 |
Formation de John Ruesch
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Astria Therapeutics, Inc.
Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for rare and niche allergic & immunological diseases | Health Technology |
Valparaiso University
Valparaiso University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Surface Oncology, Inc.
Surface Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company that develops cancer therapies | Health Technology |
















